Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
US11028067B2 · kind B2 · utility
0Cited by
5References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2018 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Feb 7, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.